Search

Author/Creator Rob, Lukas

1. Interferon‐regulated suprabasin is essential for stress‐induced stem‐like cell conversion and therapy resistance of human malignancies. Issue 7 (10th June 2019)

Authors:
Hubackova, Sona; Pribyl, Miroslav; Kyjacova, Lenka; Moudra, Alena; Dzijak, Rastislav; Salovska, Barbora; Strnad, Hynek; Tambor, Vojtech; Imrichova, Terezie; Svec, Jiri; Vodicka, Pavel; Vaclavikova, Radka; Rob, Lukas; Bartek, Jiri; Hodny, Zdenek
Journal:
Molecular oncology
Issue:
Volume 13:Issue 7(2019)
Page Start:
1467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. ESGO statement on cervical cancer vaccination: August 2007. Issue 6 (1st October 2007)

Authors:
Vergote, Ignace; Van Der Zee, Ate Gj; Kesic, Vesna; Sert, Bilal; Robova, Helena; Rob, Lukas; Reed, Nicholas; Luesley, David M.; Leblanc, Eric; Hagen, Bjorn; Gitsch, Gerald; Du Bois, Andreas; Di Vagno, Giovanni; Colombo, Nicoletta; Beller, Uziel; Ayhan, Ali; Jacobs, Ian
Journal:
International journal of gynecological cancer
Issue:
Volume 17:Issue 6(2007)
Page Start:
1183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. Issue 1 (4th December 2018)

Authors:
Truxova, Iva; Kasikova, Lenka; Hensler, Michal; Skapa, Petr; Laco, Jan; Pecen, Ladislav; Belicova, Lucie; Praznovec, Ivan; Halaska, Michael J.; Brtnicky, Tomas; Salkova, Eva; Rob, Lukas; Kodet, Roman; Goc, Jeremy; Sautes-Fridman, Catherine; Fridman, Wolf Herman; Ryska, Ales; Galluzzi, Lorenzo; Sp...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial. Issue 1 (6th January 2022)

Authors:
Rob, Lukas; Cibula, David; Knapp, Pawel; Mallmann, Peter; Klat, Jaroslav; Minar, Lubos; Bartos, Pavel; Chovanec, Josef; Valha, Petr; Pluta, Marek; Novotny, Zdenek; Spacek, Jiri; Melichar, Bohuslav; Kieszko, Dariusz; Fucikova, Jitka; Hrnciarova, Tereza; Korolkiewicz, Roman Pawel; Hraska, Marek; Ba...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗